Dostarlimab, Chemotherapy Combo Is Cost Effective, Improves QOL for Endometrial Cancer Patients | Docwire News
The addition of dostarlimab to platinum chemotherapy is cost effective and significantly improves QOL in patients with endometrial cancer, according to a recent study.